An Intravaginal Ring to Prevent Genital Herpes and Unintended Pregnancy
A Novel, Multi-compartment Intravaginal Ring for Prevention of Genital Herpes and Unintended Pregnancy
Researchers are creating a new type of intravaginal ring designed to protect women from genital herpes, HPV, HIV, and also prevent pregnancy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oak Crest Institute of Science NIH-funded |
| Lab location | 1 site (Monrovia, United States) |
| Project ID | NIH-11190933 on NIH RePORTER |
What this research studies
This project is developing a new intravaginal ring that combines several protective features into one easy-to-use device. It will deliver an antiviral medicine that works against herpes, HPV, and HIV, along with a non-hormonal contraceptive to prevent pregnancy. The goal is to offer a long-lasting, controlled release of these medicines, providing a convenient option for women who want to avoid both sexually transmitted infections and pregnancy.
Who could benefit from this research
Good fit: This research is ultimately intended for women who are at risk of sexually transmitted infections like herpes, HPV, and HIV, and who also desire contraception.
Not a fit: Patients who are not sexually active or who do not require contraception would not directly benefit from this specific product.
Why it matters
Potential benefit: If successful, this new intravaginal ring could offer women a discreet, user-friendly way to protect themselves from multiple sexually transmitted infections and unintended pregnancy with a single product.
How similar studies have performed: While the concept of multipurpose prevention products has shown promise in motivating use, this particular combination of antiviral agents and contraceptive in a novel intravaginal ring platform represents a new and integrated approach.
Where this research is happening
Monrovia, United States
- Oak Crest Institute of Science — Monrovia, United States (Active)
Researchers
- Principal investigator: Baum, Marc Michael — Oak Crest Institute of Science
- Study coordinator: Baum, Marc Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.